BIOMOTCPharmaceutical PreparationsFiscal year ends December 31

BIOMOLECULAR LIFE HOLDINGS, INC.

Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 19, 2015

$0.79−0.02 (-2.47%)

Close on Oct 19, 2026

Market cap: $67.51M
P/E (TTM): –
Dividend yield: –

Debt

Borrowings on the balance sheet, Sep 30, 2015

Biomolecular Life reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Bond issues

Individual notes and bonds outstanding

Bond-level data is not connected yet

Coupon, maturity and amount of each note will come from the debt footnote in Biomolecular Life's annual report. Trading prices and yields need FINRA TRACE data.

Where these numbers come from

Parsed from the XBRL in Biomolecular Life's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20000 reverse split on Apr 16, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BIOM.

Company	Revenue	Growth
IDYA	$234.13M	–
TNGX	$53.81M	+121.5%
HIND	$129.72K	-67.1%
LSTA	$100.00K	-90.7%
BIOM	$0	–
BPTH	–	–

Company

Exchange: OTC
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 1
SEC CIK: 1091326

Advertisement
300 × 250